Good Laboratory practice Good Laboratory practices in Pharmaceutical industry Document No.: GLP/00001 Table of content WHO Good document practice Heading 1 Heading 2 Heading 3 Heading 4 Heading 5 Heading 6 INTRODUCTION HYPOTHESIS MATERIALS WHO Good document practice The need to implement quality standards in drug research, development and testing; the situation in developing countries and the role of WHO/TDR Tropical diseases are a major public health problem in developing countries (Disease Endemic Countries – DECs). For many of these diseases no new, effective and affordable medicines have been developed, while older therapeutic agents are increasingly compromised by the emergence of resistance. Because multinational pharmaceutical companies have not traditionally focused on tropical disease research and development (R&D), WHO has initiated R&D programmes in a number of priority areas such as malaria. WHO’s Special Programme for Res